NAFDAC: Deleject Needle Alert Published in Error, Products Safe

"Investigation of the manufacturing company, HMA, found no non-conformity with Good Manufacturing Practice (GMP) requirements, suggesting that the reported issue could have resulted from a supply-chain challenge rather than a manufacturing defect." NAFDAC 

The National Agency for Food and Drug Administration and Control (NAFDAC) has clarified that a public alert concerning alleged contamination of Deleject Disposable Needles was published on its website in error, assuring Nigerians that the products remain safe for use.

The clarification followed the publication of Public Alert No. 042/2026, which reported the presence of whitish particulate matter in Deleject Disposable Needle Batch No. 240605.

In a statement signed by the Director of Post-Marketing Surveillance, Mr. Bitrus Fraden, NAFDAC explained that the complaint behind the alert was lodged by Pharm. Jiyah Dadi, whose pharmacy is located at No. 1, Aliyu Turaki, Off Isa Kaita Road, Malali, Kaduna.

According to the agency, the affected Deleject syringes were purchased from Zagbayi Pharmacy, Calabar Road, Off Kano Road, Kaduna.

NAFDAC said its investigation of the manufacturing company, HMA, found no non-conformity with Good Manufacturing Practice (GMP) requirements, suggesting that the reported issue could have resulted from a supply-chain challenge rather than a manufacturing defect.

“The matter had earlier undergone appropriate regulatory review and investigation and was satisfactorily resolved several months ago,” the agency stated.

It further stressed that there are currently no quality, safety or regulatory concerns warranting the publication of an alert on Deleject Disposable Needle products currently available on the Nigerian market.

“Deleject Disposable Needle products in distribution are in good and acceptable condition,” NAFDAC said, adding that the products had met applicable quality requirements and regulatory expectations for use.

The agency also noted that there was no evidence indicating any quality or safety risk to healthcare providers, patients, distributors or members of the public.

NAFDAC therefore urged healthcare providers, distributors and other stakeholders to disregard the erroneous publication, assuring them of the quality and safety of Deleject Disposable Needles.

“The publication is regretted and should be ignored,” Fraden said.